These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 431997)
1. Kinetics of phenylalanine disappearance after intravenous load in phenylketonuria and its genetic variants. Rey F; Blandin-Savoja F; Rey J Pediatr Res; 1979 Jan; 13(1):21-5. PubMed ID: 431997 [No Abstract] [Full Text] [Related]
2. Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria. Kaufman S; Berlow S; Summer GK; Milstien S; Schulman JD; Orloff S; Spielberg S; Pueschel S N Engl J Med; 1978 Sep; 299(13):673-9. PubMed ID: 683251 [TBL] [Abstract][Full Text] [Related]
3. Phenylketonuria due to a deficiency of dihydropteridine reductase. Kaufman S; Holtzman NA; Milstien S; Butler LJ; Krumholz A N Engl J Med; 1975 Oct; 293(16):785-90. PubMed ID: 1160969 [TBL] [Abstract][Full Text] [Related]
4. [Hyperphenylalaninaemia with normal phenylalanine-hydroxylase activity and a deficiency of tetrahydrobiopterin and dihydropteridine reductase]. Rey F; Harpey JP; Leeming RJ; Blair JA; Aicardi J; Rey J Arch Fr Pediatr; 1977; 34(7 Suppl):CIX-CXX. PubMed ID: 931522 [TBL] [Abstract][Full Text] [Related]
5. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction. Smith I; Clayton BE; Wolff OH Lancet; 1975 May; 1(7916):1108-11. PubMed ID: 49470 [TBL] [Abstract][Full Text] [Related]
7. Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro. Bartholomé K; Byrd DJ; Kaufman S; Milstien S Pediatrics; 1977 May; 59(5):757-61. PubMed ID: 300866 [TBL] [Abstract][Full Text] [Related]
8. Review of current practices in management of inherited disorders of amino acid metabolism in Western Europe. Wachtel U Hum Nutr Appl Nutr; 1986; 40 Suppl 1():61-9. PubMed ID: 3528074 [TBL] [Abstract][Full Text] [Related]
9. Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia. Bartholomé K; Lutz P; Bickel H Pediatr Res; 1975 Dec; 9(12):899-903. PubMed ID: 1196708 [TBL] [Abstract][Full Text] [Related]
13. Atypical PKU with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro. Leeming RJ; Smith I Arch Dis Child; 1979 Feb; 54(2):166-7. PubMed ID: 434898 [No Abstract] [Full Text] [Related]
14. ["Transitory" phenylketonuria. A permanent deficit]. Rey F; Leeming RJ; Curtius HC; Niederwieser A; Viscontini M; Rey J Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):XLVIII-LV. PubMed ID: 539882 [TBL] [Abstract][Full Text] [Related]
15. [Phenylalanine hydroxylase activity in hyperphenyl-alaninemia and classical phenylketonuria]. Grimm U; Knapp A; Tischer W; Schlenzka K Acta Biol Med Ger; 1972; 28(3):549-52. PubMed ID: 5049643 [No Abstract] [Full Text] [Related]
16. [Biogenic amines and hyperphenylalaninemia (author's transl)]. Tada K; Narisawa K Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1765-71. PubMed ID: 7029642 [No Abstract] [Full Text] [Related]
17. [Comparative effects of different inhibitors of phenylalanine hydroxylase and dihydropteridine reductase. In vivo and in vitro study in rats]. Charpentier C; Domange C; Wolf M; Barthon F; Laggoune B; Lemonnier A Arch Fr Pediatr; 1978 Dec; 35(10 Suppl):93-101. PubMed ID: 571268 [TBL] [Abstract][Full Text] [Related]